These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 25481034

  • 1. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
    Kojarunchitt T, Baldursdottir S, Dong YD, Boyd BJ, Rades T, Hook S.
    Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
    [Abstract] [Full Text] [Related]

  • 2. Development and characterisation of modified poloxamer 407 thermoresponsive depot systems containing cubosomes.
    Kojarunchitt T, Hook S, Rizwan S, Rades T, Baldursdottir S.
    Int J Pharm; 2011 Apr 15; 408(1-2):20-6. PubMed ID: 21272624
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nanostructured Cubosomes in a Thermoresponsive Depot System: An Alternative Approach for the Controlled Delivery of Docetaxel.
    Rarokar NR, Saoji SD, Raut NA, Taksande JB, Khedekar PB, Dave VS.
    AAPS PharmSciTech; 2016 Apr 15; 17(2):436-45. PubMed ID: 26208439
    [Abstract] [Full Text] [Related]

  • 5. The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle.
    Sherif S, Bendas ER, Badawy S.
    Eur J Pharm Biopharm; 2014 Feb 15; 86(2):251-9. PubMed ID: 24056055
    [Abstract] [Full Text] [Related]

  • 6. Thermosensitive micelles-hydrogel hybrid system based on poloxamer 407 for localized delivery of paclitaxel.
    Ju C, Sun J, Zi P, Jin X, Zhang C.
    J Pharm Sci; 2013 Aug 15; 102(8):2707-17. PubMed ID: 23839931
    [Abstract] [Full Text] [Related]

  • 7. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
    Gratieri T, Gelfuso GM, de Freitas O, Rocha EM, Lopez RF.
    Eur J Pharm Biopharm; 2011 Oct 15; 79(2):320-7. PubMed ID: 21641994
    [Abstract] [Full Text] [Related]

  • 8. Poloxamer 407-chitosan grafted thermoresponsive hydrogels achieve synchronous and sustained release of antigen and adjuvant from single-shot vaccines.
    Bobbala S, Gibson B, Gamble AB, McDowell A, Hook S.
    Immunol Cell Biol; 2018 Jul 15; 96(6):656-665. PubMed ID: 29499080
    [Abstract] [Full Text] [Related]

  • 9. Characterization of gelation process and drug release profile of thermosensitive liquid lecithin/poloxamer 407 based gels as carriers for percutaneous delivery of ibuprofen.
    Djekic L, Krajisnik D, Martinovic M, Djordjevic D, Primorac M.
    Int J Pharm; 2015 Jul 25; 490(1-2):180-9. PubMed ID: 26002567
    [Abstract] [Full Text] [Related]

  • 10. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery.
    Gordon S, Saupe A, McBurney W, Rades T, Hook S.
    J Pharm Pharmacol; 2008 Dec 25; 60(12):1591-600. PubMed ID: 19000363
    [Abstract] [Full Text] [Related]

  • 11. Thermoreversible in situ gelling poloxamer-based systems with chitosan nanocomplexes for prolonged subcutaneous delivery of heparin: design and in vitro evaluation.
    Radivojša M, Grabnar I, Ahlin Grabnar P.
    Eur J Pharm Sci; 2013 Sep 27; 50(1):93-101. PubMed ID: 23524253
    [Abstract] [Full Text] [Related]

  • 12. Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses.
    Rizwan SB, McBurney WT, Young K, Hanley T, Boyd BJ, Rades T, Hook S.
    J Control Release; 2013 Jan 10; 165(1):16-21. PubMed ID: 23142776
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide.
    Erfani Jabarian L, Rouini MR, Atyabi F, Foroumadi A, Nassiri SM, Dinarvand R.
    Eur J Pharm Sci; 2013 Jan 23; 48(1-2):87-96. PubMed ID: 23131800
    [Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.
    He W, Guo X, Feng M, Mao N.
    Int J Pharm; 2013 Dec 31; 458(2):305-14. PubMed ID: 24409520
    [Abstract] [Full Text] [Related]

  • 15. Formulation, functional evaluation and ex vivo performance of thermoresponsive soluble gels - A platform for therapeutic delivery to mucosal sinus tissue.
    Pandey P, Cabot PJ, Wallwork B, Panizza BJ, Parekh HS.
    Eur J Pharm Sci; 2017 Jan 01; 96():499-507. PubMed ID: 27771516
    [Abstract] [Full Text] [Related]

  • 16. Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity.
    Jones DS, Bruschi ML, de Freitas O, Gremião MP, Lara EH, Andrews GP.
    Int J Pharm; 2009 May 08; 372(1-2):49-58. PubMed ID: 19429268
    [Abstract] [Full Text] [Related]

  • 17. Influence of oleic acid on the rheology and in vitro release of lumiracoxib from poloxamer gels.
    Moreira TS, de Sousa VP, Pierre MB.
    J Pharm Pharm Sci; 2010 May 08; 13(2):286-302. PubMed ID: 20816013
    [Abstract] [Full Text] [Related]

  • 18. Syringeable Pluronic-α-cyclodextrin supramolecular gels for sustained delivery of vancomycin.
    Simões SM, Veiga F, Torres-Labandeira JJ, Ribeiro AC, Sandez-Macho MI, Concheiro A, Alvarez-Lorenzo C.
    Eur J Pharm Biopharm; 2012 Jan 08; 80(1):103-12. PubMed ID: 22005155
    [Abstract] [Full Text] [Related]

  • 19. In vivo investigation of twin-screw extruded lipid implants for vaccine delivery.
    Even MP, Young K, Winter G, Hook S, Engert J.
    Eur J Pharm Biopharm; 2014 Jul 08; 87(2):338-46. PubMed ID: 24607791
    [Abstract] [Full Text] [Related]

  • 20. Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.
    Yang X, Trinh HM, Agrahari V, Sheng Y, Pal D, Mitra AK.
    AAPS PharmSciTech; 2016 Apr 08; 17(2):294-306. PubMed ID: 26085051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.